We provide you with 20 years of free, institutional-grade data for KALV stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of KALV. Explore the full financial landscape of KALV stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$1,556,460
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Palleiko Benjamin L | Sale | -7,294 | $15.84 | $115,537 | 2025-09-09 |
| Palleiko Benjamin L | Derivatives Exercise | 15,625 | 2025-09-09 | ||
| Palleiko Benjamin L | RSU | 15,625 | 2025-09-09 | ||
| Yea Christopher | Sale | -1,954 | $13.42 | $26,223 | 2025-08-26 |
| Yea Christopher | Derivatives Exercise | 3,125 | 2025-08-26 | ||
| Yea Christopher | RSU | 3,125 | 2025-08-26 | ||
| Sweeny Nicole | Sale | -1,480 | $13.42 | $19,862 | 2025-08-26 |
| Sweeny Nicole | Derivatives Exercise | 5,000 | 2025-08-26 | ||
| Sweeny Nicole | RSU | 5,000 | 2025-08-26 | ||
| Audhya Paul K. | Sale | -2,336 | $13.42 | $31,349 | 2025-08-26 |
| Audhya Paul K. | Derivatives Exercise | 5,000 | 2025-08-26 | ||
| Audhya Paul K. | RSU | 5,000 | 2025-08-26 | ||
| Audhya Paul K. | Sale | -2,942 | $13.22 | $38,901 | 2025-08-25 |
| Audhya Paul K. | Derivatives Exercise | 6,250 | 2025-08-25 | ||
| Audhya Paul K. | RSU | 6,250 | 2025-08-25 | ||
| Palleiko Benjamin L | Sale | -10,940 | $13.22 | $144,657 | 2025-08-25 |
| Palleiko Benjamin L | Derivatives Exercise | 23,250 | 2025-08-25 | ||
| Palleiko Benjamin L | RSU | 23,250 | 2025-08-25 | ||
| Yea Christopher | Sale | -2,362 | $13.22 | $31,232 | 2025-08-25 |
| Yea Christopher | Derivatives Exercise | 3,750 | 2025-08-25 | ||
| Yea Christopher | RSU | 3,750 | 2025-08-25 | ||
| Sweeny Nicole | Sale | -1,864 | $13.22 | $24,647 | 2025-08-25 |
| Sweeny Nicole | Derivatives Exercise | 6,250 | 2025-08-25 | ||
| Sweeny Nicole | RSU | 6,250 | 2025-08-25 | ||
| Palleiko Benjamin L | Sale | -4,409 | $13.19 | $58,141 | 2025-08-19 |
| Palleiko Benjamin L | Derivatives Exercise | 9,362 | 2025-08-19 | ||
| Palleiko Benjamin L | RSU | 9,362 | 2025-08-19 | ||
| Yea Christopher | Sale | -2,649 | $13.19 | $34,932 | 2025-08-19 |
| Yea Christopher | Derivatives Exercise | 4,203 | 2025-08-19 | ||
| Yea Christopher | RSU | 4,203 | 2025-08-19 | ||
| Audhya Paul K. | Sale | -2,939 | $13.19 | $38,757 | 2025-08-19 |
| Audhya Paul K. | Derivatives Exercise | 6,446 | 2025-08-19 | ||
| Audhya Paul K. | RSU | 6,446 | 2025-08-19 | ||
| Yea Christopher | Sale | -30,250 | $15.69 | $474,698 | 2025-07-10 |
| Yea Christopher | Grant, award...etc | 60,000 | 2025-07-10 | ||
| Palleiko Benjamin L | Sale | -32,979 | $15.69 | $517,523 | 2025-07-10 |
| Palleiko Benjamin L | Grant, award...etc | 87,500 | 2025-07-10 | ||
| Palleiko Benjamin L | Sale | -7,169 | $14.5 | $103,951 | 2025-06-10 |
| Palleiko Benjamin L | Derivatives Exercise | 15,625 | 2025-06-10 | ||
| Palleiko Benjamin L | RSU | 15,625 | 2025-06-10 | ||
| Yea Christopher | Sale | -1,926 | $11.31 | $21,782 | 2025-05-27 |
| Yea Christopher | Derivatives Exercise | 3,125 | 2025-05-27 | ||
| Yea Christopher | RSU | 3,125 | 2025-05-27 | ||
| Audhya Paul K. | Sale | -2,146 | $11.31 | $24,272 | 2025-05-27 |
| Audhya Paul K. | Derivatives Exercise | 5,000 | 2025-05-27 | ||
| Audhya Paul K. | RSU | 5,000 | 2025-05-27 | ||
| Audhya Paul K. | Sale | -2,689 | $11.88 | $31,933 | 2025-05-23 |
| Audhya Paul K. | Derivatives Exercise | 6,250 | 2025-05-23 | ||
| Audhya Paul K. | RSU | 6,250 | 2025-05-23 | ||
| Palleiko Benjamin L | Sale | -9,999 | $11.88 | $118,743 | 2025-05-23 |
| Palleiko Benjamin L | Derivatives Exercise | 23,250 | 2025-05-23 | ||
| Palleiko Benjamin L | RSU | 23,250 | 2025-05-23 | ||
| Yea Christopher | Sale | -2,317 | $11.88 | $27,516 | 2025-05-23 |
| Yea Christopher | Derivatives Exercise | 3,750 | 2025-05-23 | ||
| Yea Christopher | RSU | 3,750 | 2025-05-23 | ||
| Yea Christopher | Sale | -2,600 | $11.84 | $30,791 | 2025-05-20 |
| Yea Christopher | Derivatives Exercise | 4,205 | 2025-05-20 | ||
| Yea Christopher | RSU | 4,205 | 2025-05-20 | ||
| Palleiko Benjamin L | Sale | -3,808 | $11.84 | $45,097 | 2025-05-20 |
| Palleiko Benjamin L | Derivatives Exercise | 9,364 | 2025-05-20 | ||
| Palleiko Benjamin L | RSU | 9,364 | 2025-05-20 | ||
| Audhya Paul K. | Sale | -2,776 | $11.84 | $32,876 | 2025-05-20 |
| Audhya Paul K. | Derivatives Exercise | 6,447 | 2025-05-20 | ||
| Audhya Paul K. | RSU | 6,447 | 2025-05-20 | ||
| Venrock Healthcare Capital Partners III, L.P. | Open Market Purchase | 25,000 | $9.42 | 2025-04-11 | |
| Palleiko Benjamin L | Sale | -6,669 | $11.97 | $79,828 | 2025-03-10 |
| Palleiko Benjamin L | Derivatives Exercise | 15,625 | 2025-03-10 | ||
| Palleiko Benjamin L | RSU | 15,625 | 2025-03-10 | ||
| Yea Christopher | Sale | -1,918 | $10.02 | $19,218 | 2025-02-25 |
| Yea Christopher | Derivatives Exercise | 3,125 | 2025-02-25 | ||
| Yea Christopher | RSU | 3,125 | 2025-02-25 | ||
| Audhya Paul K. | Sale | -2,394 | $10.02 | $23,988 | 2025-02-25 |
| Audhya Paul K. | Derivatives Exercise | 5,000 | 2025-02-25 | ||
| Audhya Paul K. | RSU | 5,000 | 2025-02-25 | ||
| Palleiko Benjamin L | Sale | -5,104 | $9.82 | $50,143 | 2025-02-19 |
| Palleiko Benjamin L | Derivatives Exercise | 9,363 | 2025-02-19 | ||
| Palleiko Benjamin L | RSU | 9,363 | 2025-02-19 | ||
| Audhya Paul K. | Sale | -3,125 | $9.82 | $30,701 | 2025-02-19 |
| Audhya Paul K. | Derivatives Exercise | 6,447 | 2025-02-19 | ||
| Audhya Paul K. | RSU | 6,447 | 2025-02-19 | ||
| Yea Christopher | Sale | -2,601 | $9.82 | $25,553 | 2025-02-19 |
| Yea Christopher | Derivatives Exercise | 4,204 | 2025-02-19 | ||
| Yea Christopher | RSU | 4,204 | 2025-02-19 | ||
| Venrock Healthcare Capital Partners III, L.P. | Open Market Purchase | 161,700 | $9.23 | 2025-02-14 | |
| Venrock Healthcare Capital Partners III, L.P. | Open Market Purchase | 104,489 | $9.29 | 2025-02-11 | |
| Venrock Healthcare Capital Partners III, L.P. | Open Market Purchase | 70,023 | $8.76 | 2025-02-03 | |
| Palleiko Benjamin L | Sale | -7,627 | $9.75 | $74,363 | 2024-12-09 |
| Palleiko Benjamin L | Derivatives Exercise | 15,625 | 2024-12-09 | ||
| Palleiko Benjamin L | RSU | 15,625 | 2024-12-09 | ||
| Audhya Paul K. | Sale | -2,187 | $9.87 | $21,586 | 2024-11-27 |
| Audhya Paul K. | Derivatives Exercise | 5,000 | 2024-11-27 | ||
| Audhya Paul K. | RSU | 5,000 | 2024-11-27 | ||
| Yea Christopher | Sale | -1,963 | $9.87 | $19,378 | 2024-11-27 |
| Yea Christopher | Derivatives Exercise | 3,125 | 2024-11-27 | ||
| Yea Christopher | RSU | 3,125 | 2024-11-27 | ||
| Yea Christopher | Sale | -7,192 | $9.26 | $66,573 | 2024-11-19 |
| Yea Christopher | Derivatives Exercise | 11,496 | 2024-11-19 | ||
| Yea Christopher | RSU | 4,205 | 2024-11-19 | ||
| Palleiko Benjamin L | Sale | -14,400 | $9.26 | $133,294 | 2024-11-19 |
| Palleiko Benjamin L | Derivatives Exercise | 30,198 | 2024-11-19 | ||
| Palleiko Benjamin L | RSU | 9,364 | 2024-11-19 | ||
| Audhya Paul K. | Sale | -8,077 | $9.26 | $74,766 | 2024-11-19 |
| Audhya Paul K. | Derivatives Exercise | 18,531 | 2024-11-19 | ||
| Audhya Paul K. | RSU | 6,447 | 2024-11-19 | ||
| Palleiko Benjamin L | Sale | -7,352 | $12.19 | $89,622 | 2024-09-10 |
| Palleiko Benjamin L | Derivatives Exercise | 15,625 | 2024-09-10 | ||
| Palleiko Benjamin L | RSU | 15,625 | 2024-09-10 | ||
| Yea Christopher | Sale | -1,916 | $12.4 | $23,758 | 2024-08-26 |
| Yea Christopher | Derivatives Exercise | 3,125 | 2024-08-26 | ||
| Yea Christopher | RSU | 3,125 | 2024-08-26 | ||
| Audhya Paul K. | Sale | -2,135 | $12.4 | $26,474 | 2024-08-26 |
| Audhya Paul K. | Derivatives Exercise | 5,000 | 2024-08-26 | ||
| Audhya Paul K. | RSU | 5,000 | 2024-08-26 | ||
| Audhya Paul K. | Sale | -7,973 | $12.01 | $95,782 | 2024-08-21 |
| Audhya Paul K. | Derivatives Exercise | 18,528 | 2024-08-21 | ||
| Audhya Paul K. | RSU | 6,445 | 2024-08-21 | ||
| Yea Christopher | Sale | -7,102 | $12.01 | $85,318 | 2024-08-21 |
| Yea Christopher | Derivatives Exercise | 11,495 | 2024-08-21 | ||
| Yea Christopher | RSU | 4,203 | 2024-08-21 | ||
| Palleiko Benjamin L | Sale | -14,215 | $12.01 | $170,769 | 2024-08-21 |
| Palleiko Benjamin L | Derivatives Exercise | 30,195 | 2024-08-21 | ||
| Palleiko Benjamin L | RSU | 9,362 | 2024-08-21 | ||
| Palleiko Benjamin L | Sale | -7,465 | $11.53 | $86,068 | 2024-06-10 |
| Palleiko Benjamin L | Derivatives Exercise | 15,625 | 2024-06-10 | ||
| Palleiko Benjamin L | RSU | 15,625 | 2024-06-10 | ||
| Palleiko Benjamin L | Sale | -21,959 | $11.76 | $258,337 | 2024-05-21 |
| Palleiko Benjamin L | Derivatives Exercise | 51,031 | 2024-05-21 | ||
| Palleiko Benjamin L | RSU | 9,364 | 2024-05-21 | ||
| Yea Christopher | Sale | -11,610 | $11.76 | $136,586 | 2024-05-21 |
| Yea Christopher | Derivatives Exercise | 18,789 | 2024-05-21 | ||
| Yea Christopher | RSU | 4,205 | 2024-05-21 | ||
| Audhya Paul K. | Sale | -13,175 | $11.76 | $154,997 | 2024-05-21 |
| Audhya Paul K. | Derivatives Exercise | 30,614 | 2024-05-21 | ||
| Audhya Paul K. | RSU | 6,447 | 2024-05-21 | ||
| Feener Edward P. | Sale | -8,088 | $11.76 | $95,151 | 2024-05-21 |
| Feener Edward P. | Derivatives Exercise | 18,789 | 2024-05-21 | ||
| Feener Edward P. | RSU | 4,205 | 2024-05-21 | ||
| Feener Edward P. | Sale | -28,288 | $14.11 | $399,279 | 2024-02-21 |
| Feener Edward P. | Derivatives Exercise | 18,788 | 2024-02-21 | ||
| Feener Edward P. | RSU | 4,204 | 2024-02-21 | ||
| Yea Christopher | Sale | -12,053 | $14.11 | $170,124 | 2024-02-21 |
| Yea Christopher | Derivatives Exercise | 18,788 | 2024-02-21 | ||
| Yea Christopher | RSU | 4,204 | 2024-02-21 | ||
| Palleiko Benjamin L | Sale | -22,802 | $14.11 | $321,846 | 2024-02-21 |
| Palleiko Benjamin L | Derivatives Exercise | 51,029 | 2024-02-21 | ||
| Palleiko Benjamin L | RSU | 9,363 | 2024-02-21 | ||
| Audhya Paul K. | Sale | -14,295 | $14.12 | $201,774 | 2024-02-21 |
| Audhya Paul K. | Derivatives Exercise | 30,613 | 2024-02-21 | ||
| Audhya Paul K. | RSU | 6,447 | 2024-02-21 | ||
| Crockett Thomas Andrew | Sale | -24,888 | $14.11 | $351,289 | 2024-02-21 |
| Crockett Thomas Andrew | Derivatives Exercise | 54,415 | 2024-02-21 | ||
| Crockett Thomas Andrew | RSU | 12,749 | 2024-02-21 | ||
| Feener Edward P. | Sale | -28,171 | $15.01 | $422,827 | 2024-02-16 |
| Yea Christopher | Sale | -39,886 | $15.01 | $598,661 | 2024-02-16 |
| Crockett Thomas Andrew | Sale | -58,356 | $15.01 | $875,883 | 2024-02-16 |
| Palleiko Benjamin L | Sale | -40,855 | $15.01 | $613,205 | 2024-02-16 |
| Palleiko Benjamin L | Grant, award...etc | 87,500 | 2024-02-13 | ||
| Feener Edward P. | Grant, award...etc | 60,000 | 2024-02-13 | ||
| Crockett Thomas Andrew | Grant, award...etc | 122,500 | 2024-02-13 | ||
| Yea Christopher | Grant, award...etc | 60,000 | 2024-02-13 | ||
| Venrock Healthcare Capital Partners III, L.P. | Open Market Purchase | 86,048 | $14.74 | 2024-02-08 | |
| Crockett Thomas Andrew | Sale | -10,000 | $16.18 | $161,751 | 2024-02-05 |
| Venrock Healthcare Capital Partners III, L.P. | Open Market Purchase | 88,099 | $14.47 | 2024-02-01 | |
| Venrock Healthcare Capital Partners III, L.P. | Open Market Purchase | 91,804 | $12.73 | 2024-01-29 | |
| Venrock Healthcare Capital Partners III, L.P. | Open Market Purchase | 99,129 | $12.55 | 2024-01-24 | |
| Venrock Healthcare Capital Partners III, L.P. | Open Market Purchase | 143,605 | $12.6 | 2024-01-19 | |
| Venrock Healthcare Capital Partners III, L.P. | Open Market Purchase | 26,246 | $12.68 | 2024-01-16 | |
| Feener Edward P. | Sale | -22,679 | $13.03 | $295,514 | 2024-01-12 |
| Venrock Healthcare Capital Partners III, L.P. | Open Market Purchase | 137,700 | $12.44 | 2024-01-10 | |
| Feener Edward P. | Sale | -17,321 | $13.01 | $225,301 | 2024-01-10 |
| Venrock Healthcare Capital Partners III, L.P. | Open Market Purchase | 59,369 | $12.2 | 2024-01-05 | |
| Venrock Healthcare Capital Partners III, L.P. | Open Market Purchase | 519,017 | $11.97 | 2023-12-29 | |
| Crockett Thomas Andrew | Sale | -30,000 | $12.02 | $360,453 | 2023-12-28 |
| Yea Christopher | Sale | -7,113 | $8.23 | $58,535 | 2023-11-21 |
| Yea Christopher | Derivatives Exercise | 11,497 | 2023-11-21 | ||
| Yea Christopher | RSU | 4,205 | 2023-11-21 | ||
| Crockett Thomas Andrew | Sale | -14,807 | $8.23 | $121,851 | 2023-11-21 |
| Crockett Thomas Andrew | Derivatives Exercise | 33,583 | 2023-11-21 | ||
| Crockett Thomas Andrew | RSU | 12,750 | 2023-11-21 | ||
| Palleiko Benjamin L | Sale | -13,008 | $8.23 | $107,047 | 2023-11-21 |
| Palleiko Benjamin L | Derivatives Exercise | 30,197 | 2023-11-21 | ||
| Palleiko Benjamin L | RSU | 9,364 | 2023-11-21 | ||
| Feener Edward P. | Sale | -4,958 | $8.23 | $40,801 | 2023-11-21 |
| Feener Edward P. | Derivatives Exercise | 11,497 | 2023-11-21 | ||
| Feener Edward P. | RSU | 4,205 | 2023-11-21 | ||
| Audhya Paul K. | Sale | -7,985 | $8.23 | $65,711 | 2023-11-21 |
| Audhya Paul K. | Derivatives Exercise | 18,530 | 2023-11-21 | ||
| Audhya Paul K. | RSU | 6,447 | 2023-11-21 | ||
| Cha Albert | Sale | -18,000 | $10.5 | $189,050 | 2023-09-13 |
| Cha Albert | Derivatives Exercise | 18,000 | 2023-09-13 | ||
| Crockett Thomas Andrew | Sale | -14,876 | $10.73 | $159,602 | 2023-08-21 |
| Crockett Thomas Andrew | Derivatives Exercise | 33,582 | 2023-08-21 | ||
| Crockett Thomas Andrew | RSU | 12,749 | 2023-08-21 | ||
| Palleiko Benjamin L | Sale | -13,067 | $10.73 | $140,192 | 2023-08-21 |
| Palleiko Benjamin L | Derivatives Exercise | 30,195 | 2023-08-21 | ||
| Palleiko Benjamin L | RSU | 9,362 | 2023-08-21 | ||
| Yea Christopher | Sale | -7,142 | $10.73 | $76,624 | 2023-08-21 |
| Yea Christopher | Derivatives Exercise | 11,494 | 2023-08-21 | ||
| Yea Christopher | RSU | 4,203 | 2023-08-21 | ||
| Audhya Paul K. | Sale | -8,020 | $10.73 | $86,045 | 2023-08-21 |
| Audhya Paul K. | Derivatives Exercise | 18,529 | 2023-08-21 | ||
| Audhya Paul K. | RSU | 6,446 | 2023-08-21 | ||
| Feener Edward P. | Sale | -4,976 | $10.73 | $53,386 | 2023-08-21 |
| Feener Edward P. | Derivatives Exercise | 11,494 | 2023-08-21 | ||
| Feener Edward P. | RSU | 4,203 | 2023-08-21 |
The information provided in this report about KALV stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
KalVista Pharmaceuticals, Inc(NASDAQ:KALV)Â 
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HA...
Website: http://www.kalvista.com
Founded: 2004
Full Time Employees: 56
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends